Moosa Patel to Humans
This is a "connection" page, showing publications Moosa Patel has written about Humans.
Connection Strength
0,360
-
The prognostic impact of monocyte fluorescence, immunosuppressive monocytes and peripheral blood immune cell numbers in HIV-associated Diffuse Large B-cell Lymphoma. PLoS One. 2023; 18(1):e0280044.
Score: 0,066
-
HIV-associated DLBCL: Clinicopathological factors including dual-colour chromogenic in situ hybridisation to assess MYC gene copies. Ann Diagn Pathol. 2022 Jun; 58:151913.
Score: 0,062
-
Peripheral T cell lymphoma. Indian J Med Res. 2018 05; 147(5):439-441.
Score: 0,048
-
An Expanded Spectrum of High-Grade B-Cell Non-Hodgkin Lymphomas Involving the Cervicovaginal Region. Int J Gynecol Pathol. 2015 Nov; 34(6):564-9.
Score: 0,040
-
Human immunodeficiency virus infection and chronic myeloid leukemia. Leuk Res. 2012 Nov; 36(11):1334-8.
Score: 0,032
-
Derangements of immunological proteins in HIV-associated diffuse large B-cell lymphoma: the frequency and prognostic impact. Front Cell Infect Microbiol. 2024; 14:1340096.
Score: 0,018
-
Hyperlipidemic myeloma, a rare form of acquired dysbetalipoproteinemia, in an HIV seropositive African female. Clin Chim Acta. 2021 Sep; 520:71-75.
Score: 0,015
-
MYC status in HIV-associated plasmablastic lymphoma: dual-colour CISH, FISH and immunohistochemistry. Histopathology. 2021 Jul; 79(1):86-95.
Score: 0,015
-
Feasibility of Cell-Free DNA Collection and Clonal Immunoglobulin Sequencing in South African Patients With HIV-Associated Lymphoma. JCO Glob Oncol. 2021 04; 7:611-621.
Score: 0,015
-
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study. Leuk Lymphoma. 2019 12; 60(14):3375-3385.
Score: 0,013
-
Molecular Diagnostics for AIDS Lymphoma Diagnosis in South Africa and the Potential for Other Low- and Middle-Income Countries. J Glob Oncol. 2018 09; 4:1-6.
Score: 0,011
-
Hepatosplenic T-cell lymphoma: A case series. Hematol Oncol Stem Cell Ther. 2015 Jun; 8(2):78-84.
Score: 0,009
-
High efficacy and low toxicity of short-course oral valganciclovir as pre-emptive therapy for hematopoietic stem cell transplant cytomegalovirus infection. Hematol Oncol Stem Cell Ther. 2010; 3(3):116-20.
Score: 0,007
-
The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995-2004. Int J Cancer. 2008 May 15; 122(10):2260-5.
Score: 0,006
-
Risk factors for high anti-HHV-8 antibody titers (> or =1:51,200) in black, HIV-1 negative South African cancer patients: a case control study. BMC Infect Dis. 2003 Sep 12; 3:21.
Score: 0,004